查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1153901

介入性心臟学及末梢血管设备市场:趋势，机会及竞争分析

Interventional Cardiology and Peripheral Vascular Device Market: Trends, Opportunities and Competitive Analysis
出版日期: | 出版商: Lucintel | 英文 201 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球介入性心臟学及末梢血管设备的市场规模，预计2022年～至2027年以5.6％的年复合成长率扩大，估计至2027年达到316亿美元。

本报告提供全球介入性心臟学及末梢血管设备市场相关调查，市场概要，以及各类型，各设备，各最终用途，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场背景与分类

第3章 市场趋势与预测分析:2016年～2027年

  • 宏观经济的趋势与预测
  • 全球介入性心臟学及末梢血管设备市场趋势与预测
  • 全球介入性心臟学及末梢血管设备市场，各类型
  • 全球介入性心臟学及末梢血管设备市场，各设备
  • 全球介入性心臟学及末梢血管设备市场，各最终用途

第4章 市场趋势与预测分析，各地区

  • 全球介入性心臟学及末梢血管设备市场，各地区
  • 北美的介入性心臟学及末梢血管设备市场
  • 欧洲的介入性心臟学及末梢血管设备市场
  • 亚太地区的介入性心臟学及末梢血管设备市场
  • 其他各国的介入性心臟学及末梢血管设备市场

第5章 竞争分析

第6章 成本结构分析

第7章 成长机会及策略分析

  • 成长机会分析
  • 全球介入性心臟学及末梢血管设备市场上新兴趋势
  • 策略分析

第8章 主要加入企业的企业简介

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Medtronic Public Limited Company
  • C. R. Bard, Inc.
  • Cook Medical Inc.
  • Terumo Corporation
  • Cardinal Health Inc
简介目录

Interventional Cardiology and Peripheral Vascular Device Market Trends and Forecast

The future of the global interventional cardiology and peripheral vascular device market looks good with opportunities in hospitals and ambulatory surgical centers. The global interventional cardiology and peripheral vascular device market is expected to reach an estimated $31.6 billion by 2027 and is forecast to grow at a CAGR of 5.6% from 2022 to 2027. The major drivers are growing elderly population, rise in prevalence of chronic diseases, and advancements in medical technology and research.

Emerging Trends in the Interventional Cardiology and Peripheral Vascular Device Market

Emerging trends, which have a direct impact on the dynamics of the industry, include rising adoption of TAVR procedure, increasing use of bioresorbable stents, and rising adoption of drug eluting balloons.

A total of 112 figures / charts and 97 tables are provided in this 201-page report to help in your business decisions. A sample figure with some insights is shown below. To learn the scope of, benefits, companies researched and other details of interventional cardiology and peripheral vascular device market report.

Interventional Cardiology and Peripheral Vascular Device Market by Segment

In this market, interventional cardiology is the largest type market, whereas angioplasty stents is the largest device segment.

The study includes trends and forecast for the global interventional cardiology and peripheral vascular device market by type, device, end user, and region, as follows:

Interventional Cardiology and Peripheral Vascular Device Market by Type [Value ($ Million) from 2016 to 2027]:

  • Interventional Cardiology Devices
  • Peripheral Vascular Devices

Interventional Cardiology and Peripheral Vascular Device Market by Device [Value ($ Million) from 2016 to 2027]:

  • Angioplasty Balloons
  • Angioplasty Stents
  • Angioplasty Catheters
  • EVAR Stent Graft
  • IVC Filter
  • Embolic Protection Devices
  • Guidewires
  • Arteriotomy Closure Devices
  • Intravascular Ultrasound System
  • Synthetic Surgical Graft

Interventional Cardiology and Peripheral Vascular Device Market by End User [Value ($ Million) from 2021 and 2027]:

  • Hospitals
  • Ambulatory Surgical Centers

Interventional Cardiology and Peripheral Vascular Device Market by Region [Value ($ Million) from 2016 to 2027]:

  • North America

US

Mexico

Canada

  • Europe

United Kingdom

Germany

France

Spain

  • APAC

China

Japan

India

  • ROW

Brazil

List of Interventional Cardiology and Peripheral Vascular Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, interventional cardiology and peripheral vascular device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the interventional cardiology and peripheral vascular device companies profiled in this report include:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Medtronics Public Limited Company
  • C. R. Bard, Inc.
  • Cook Medical Inc.
  • Terumo Corporation
  • Cardinal Health Inc.
  • Interventional Cardiology and Peripheral Vascular Device Market Insights
  • Lucintel forecasts that interventional cardiology is expected to witness significant growth over the forecast period because of new technology innovations and aging population.
  • Within global interventional cardiology and peripheral vascular device market, the largest segment by end user is projected to be hospitals due to the growing public-private partnerships to improve access to healthcare services along with rapid developments in healthcare infrastructure and improving access to healthcare services. These are the major driving factors for growth in this segment over the forecast period.
  • North America is expected to remain the largest region because it is a large pharmaceutical manufacturing base and it is witnessing increasing technological advancements in interventional cardiology and peripheral vascular devices.
  • APAC is expected to witness the highest growth rate over the forecast period due to the presence of a large pool of respiratory patients, increasing healthcare expenditure, rapidly developing healthcare infrastructure, rising per capita income, growing middle-class population, and growing prevalence of tobacco smoking in this region.
  • Features of Global Interventional Cardiology and Peripheral Vascular Device Market
  • Market Size Estimates: Global interventional cardiology and peripheral vascular device market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2016-2021) and forecast (2022-2027) by various segments and regions.
  • Segmentation Analysis: Global interventional cardiology and peripheral vascular device market size by various segments, such as device, end user, and regions in terms of value.
  • Regional Analysis: Global interventional cardiology and peripheral vascular device market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different device, end use, and regions for global interventional cardiology and peripheral vascular device market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the global interventional cardiology and peripheral vascular device market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.
  • FAQ
  • Q1. What is the interventional cardiology and peripheral vascular device market size?
  • Answer: The global interventional cardiology and peripheral vascular device market is expected to reach an estimated $$31.6 billion by 2027.
  • Q2. What is the growth forecast for the interventional cardiology and peripheral vascular device market?
  • Answer: The interventional cardiology and peripheral vascular device market is expected to grow at a CAGR of ~5% from 2022 to 2027.
  • Q3. What are the major drivers influencing the growth of the interventional cardiology and peripheral vascular device market?
  • Answer: The major drivers of this market are growing elderly population, rise in prevalence of chronic diseases, and advancements in medical technology and research.
  • Q4. What are the major end use or end use industries for interventional cardiology and peripheral vascular devices?
  • Answer: Hospitals and ambulatory surgical centers are the major end users of interventional cardiology and peripheral vascular devices.
  • Q5. What are the emerging trends in the interventional cardiology and peripheral vascular device market?
  • Answer: Emerging trends, which have a direct impact on the dynamics of the industry, include rising adoption of TAVR procedure, increasing use of bioresorbable stents, and rising adoption of drug eluting balloons.
  • Q6. Who are the key interventional cardiology and peripheral vascular device companies?

Answer: Some of the key interventional cardiology and peripheral vascular device companies are as follows:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Medtronics Public Limited Company
  • C. R. Bard, Inc.
  • Cook Medical Inc.
  • Terumo Corporation
  • Cardinal Health Inc.
  • Q7. Which interventional cardiology and peripheral vascular device type segment will be the largest in the future?
  • Answer: Lucintel forecasts that interventional cardiology is expected to witness significant growth over the forecast period because of new technology innovations and aging population.
  • Q8 : In the interventional cardiology and peripheral vascular device market, which region is expected to be the largest in next 5 years?
  • Answer: North America will remain the largest region and Asia Pacific expected to witness the highest growth over next 5 years.
  • Q9. Do we receive customization in this report?
  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1 What are some of the most promising, high-growth opportunities for the global interventional cardiology and peripheral vascular device market by type (interventional cardiology and peripheral vascular devices), device (angioplasty balloons, angioplasty stents, angioplasty catheters, EVAR stent graft, IVC filter, embolic protection devices, guidewires, arteriotomy closure devices, intravascular ultrasound system, and synthetic surgical graft), end user (hospitals and ambulatory surgical centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2 Which segments will grow at a faster pace and why?
  • Q.3 Which regions will grow at a faster pace and why?
  • Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global interventional cardiology and peripheral vascular device market?
  • Q.5 What are the business risks and threats to the global interventional cardiology and peripheral vascular device market?
  • Q.6 What are emerging trends in this global interventional cardiology and peripheral vascular device market t and the reasons behind them?
  • Q.7 What are some changing demands of customers in the global interventional cardiology and peripheral vascular device market?
  • Q.8 What are the new developments in the global interventional cardiology and peripheral vascular device market? Which companies are leading these developments?
  • Q.9 Who are the major players in the global interventional cardiology and peripheral vascular device market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10 What are some of the competitive products and processes in the global interventional cardiology and peripheral vascular device market, and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11 What M&A activities did take place in the last five years in the global interventional cardiology and peripheral vascular device market?

Table of Contents

1. Executive Summary

2. Market Background and Classifications

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2016 to 2027

  • 3.1: Macroeconomic Trends and Forecast
  • 3.2: Global Interventional Cardiology and Peripheral Vascular Device Market Trends and Forecast
  • 3.3: Global Interventional Cardiology and Peripheral Vascular Device Market by Type
    • 3.3.1: Interventional Cardiology Devices
    • 3.3.2: Peripheral Vascular Devices
  • 3.4: Global Interventional Cardiology and Peripheral Vascular Device Market by Device
    • 3.4.1: Angioplasty Balloons
    • 3.4.2: Angioplasty Stents
    • 3.4.3: Angioplasty Catheter
    • 3.4.4: Intravascular Ultrasound System
    • 3.4.5: Guidewires
    • 3.4.6: Arteriotomy Closure Devices
    • 3.4.7: EVAR Stent Graft
    • 3.4.8: Inferior Vena Cava Filter
    • 3.4.9: Embolic Protection Device
    • 3.4.10: Synthetic Surgical Graft
  • 3.5: Global Interventional Cardiology and Peripheral Vascular Device Market by End Use

4. Market Trends and Forecast Analysis by Region

  • 4.1: Global Interventional Cardiology and Peripheral Vascular Device Market by Region
  • 4.2: North American Interventional Cardiology and Peripheral Vascular Device Market
    • 4.2.1: Market by Type: Interventional Cardiology Devices and Peripheral Vascular Devices
    • 4.2.2: Market by Device: Interventional Cardiology Devices and Peripheral Vascular Devices
    • 4.2.3: United States Interventional Cardiology and Peripheral Vascular Device Market
    • 4.2.4: Canadian Interventional Cardiology and Peripheral Vascular Device Market
  • 4.3: European Interventional Cardiology and Peripheral Vascular Device Market
    • 4.3.1: Market by Type: Interventional Cardiology Devices and Peripheral Vascular Devices
    • 4.3.2: Market by Device: Interventional Cardiology Devices and Peripheral Vascular Devices
    • 4.3.3: German Interventional Cardiology and Peripheral Vascular Device Market
    • 4.3.4: French Interventional Cardiology and Peripheral Vascular Device Market
    • 4.3.5: Interventional Cardiology and Peripheral Vascular Device Market of the United Kingdom
    • 4.3.6: Italian Interventional Cardiology and Peripheral Vascular Device Market
    • 4.3.7: Spanish Interventional Cardiology and Peripheral Vascular Device Market
  • 4.4: APAC Interventional Cardiology and Peripheral Vascular Device Market
    • 4.4.1: Market by Type: Interventional Cardiology Devices and Peripheral Vascular Devices
    • 4.4.2: Market by Device: Interventional Cardiology Devices and Peripheral Vascular Devices
    • 4.4.3: Japanese Interventional Cardiology and Peripheral Vascular Device Market
    • 4.4.4: Chinese Interventional Cardiology and Peripheral Vascular Device Market
    • 4.4.5: Indian Cardiovascular Device Market
  • 4.5: ROW Interventional Cardiology and Peripheral Vascular Device Market
    • 4.5.1: Market by Type: Interventional Cardiology Devices and Peripheral Vascular Devices
    • 4.5.2: Market by Device: Interventional Cardiology Devices and Peripheral Vascular Devices
    • 4.5.3: Brazilian Interventional Cardiology and Peripheral Vascular Device Market

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Market Share Analysis
  • 5.3: Operational Integration
  • 5.4: Geographical Reach
  • 5.5: Porter's Five Forces Analysis

6. Cost Structure Analysis

  • 6.1: Cost of Goods Sold
  • 6.2: SG&A
  • 6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis

  • 7.1: Growth Opportunity Analysis
    • 7.1.1: Growth Opportunities for the Global Interventional Cardiology and Peripheral Vascular Device Market by Type
    • 7.1.2: Growth Opportunities for the Global Interventional Cardiology and Peripheral Vascular Device Market by Region
  • 7.2: Emerging Trends in the Global Interventional Cardiology and Peripheral Vascular Device Market
  • 7.3: Strategic Analysis
    • 7.3.1: New Product Development
    • 7.3.2: Capacity Expansion of the Global Interventional Cardiology and Peripheral Vascular Device Market
    • 7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Interventional Cardiology and Peripheral Vascular Device Market
    • 7.3.4: Technology Development

8. Company Profiles of Leading Players

  • 8.1: Abbott Laboratories
  • 8.2: Boston Scientific Corporation
  • 8.3: Edwards Lifesciences Corporation
  • 8.4: Medtronic Public Limited Company
  • 8.5: C. R. Bard, Inc.
  • 8.6: Cook Medical Inc.
  • 8.7: Terumo Corporation
  • 8.8: Cardinal Health Inc